EP2073805
Aðferðir við að skammta 1,2,4-oxadíasól sem er virkt eftir inntöku í markleysubyrgingarmeðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.10.2007EP published:
4.3.2015EP application number:
07852738.9
EP translation filed:
29.5.2015Grant published:
15.6.2015EPO information:
European Patent Register
Max expiry date:
10.10.2027Expiry date:
10.10.2024
Title:
METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
Timeline
Today
11.10.2007EP application
4.3.2015EP Publication
29.5.2015Translation submitted
15.6.2015Registration published
10.10.2024Expires
Owner
Name:
PTC Therapeutics, Inc.Address:
100 Corporate Court, Middlesex Business Center, 07080, South Plainfield, NJ, US
Inventor
Name:
HIRAWAT, SamitAddress:
Chatham, NJ, US
Name:
MILLER, LangdonAddress:
Seattle, WA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
851450 PDate:
12.10.2006Country:
US
Classification
Categories:
A61K 31/4245, A61P 3/10, A61P 7/00, A61P 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 10.9.2015
Expires: 10.10.2016
Payer: Árnason Faktor
Number: 10
Paid: 6.9.2016
Expires: 10.10.2017
Payer: Árnason Faktor
Number: 11
Paid: 2.10.2017
Expires: 10.10.2018
Payer: Tego ehf.
Number: 12
Paid: 30.10.2018
Expires: 10.10.2019
Payer: Tego ehf.
Number: 13
Paid: 25.10.2019
Expires: 10.10.2020
Payer: Tego ehf.
Number: 14
Paid: 21.10.2020
Expires: 10.10.2021
Payer: Tego ehf.
Number: 15
Paid: 21.9.2021
Expires: 10.10.2022
Payer: Patice ehf.
Number: 16
Paid: 20.9.2022
Expires: 10.10.2023
Payer: Patice ehf.
Number: 17
Paid: 6.10.2023
Expires: 10.10.2024
Payer: Árnason Faktor ehf.